GRAF JAMES A (Chief Executive Officer) purchased 0.0% of their position (500.00 shares) of NKGEN BIOTECH, INC. on the open market
Open‑market purchase worth $5.0K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 5/27/2021ACC: 0001104659-21-073289
Officer10% Owner· Chief Executive Officer
Since May 2021
+500.00
Net shares
Net buyer
$5.0K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
500.00 acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+100.00
Price / share
$9.94
Trade value
$994.00
% of position
0.0%
5/25/2021
4.25M→4.25M
Common Stock
Direct
Shares
+320.00
Price / share
$9.91
Trade value
$3.17K
% of position
0.0%
5/26/2021
4.25M→4.25M
Common Stock
Direct
Shares
+80.00
Price / share
$9.93
Trade value
$794.40
% of position
0.0%
5/27/2021
4.25M→4.25M
Total
Net shares
+500.00
Net value
$4.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/25/2021 | P · Purchase | +100.00 | $9.94 | $994.00 | 0.0% | 4.25M | 4.25M |
| Common Stock Direct | 5/26/2021 | P · Purchase | +320.00 | $9.91 | $3.17K | 0.0% | 4.25M | 4.25M |
| Common Stock Direct | 5/27/2021 | P · Purchase | +80.00 | $9.93 | $794.40 | 0.0% | 4.25M | 4.25M |
| Total | +500.00 | $4.96K | ||||||
Derivative Transactions0
No derivative transactions reported